Scpharmaceuticals Inc., was incorporated as a limited liability company under the laws of the State of Delaware in February 2013. The company is a pharmaceutical company focused on developing and commercializing products with the potential to transform treatments, advance patient care and reduce medical costs. The Company's proprietary platform is designed to enable subcutaneous administration of treatments previously limited to intravenous or IV delivery. From the high cost that IV management usually requires, the company breaks this high cost requirement, which the company believes reduces the overall medical cost and improves the quality and convenience of care. 

SCPH(Delisted)

SCPH Profile